<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<html>
 <body>
  <pubmedarticleset>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32303592
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       18
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1098-5514
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          17
         </day>
        </pubdate>
       </journalissue>
       <title>
        Journal of virology
       </title>
       <isoabbreviation>
        J. Virol.
       </isoabbreviation>
      </journal>
      <articletitle>
       Human leukocyte antigen susceptibility map for SARS-CoV-2.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       JVI.00510-20
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1128/JVI.00510-20
      </elocationid>
      <abstract>
       <abstracttext>
        Genetic variability across the three major histocompatibility complex (MHC) class I genes (human leukocyte antigen [lsqb]HLA[rsqb] A, B, and C) may affect susceptibility to and severity of severe acute respiratory syndrome 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). We execute a comprehensive in silico analysis of viral peptide-MHC class I binding affinity across 145 HLA -A, -B, and -C genotypes for all SARS-CoV-2 peptides. We further explore the potential for cross-protective immunity conferred by prior exposure to four common human coronaviruses. The SARS-CoV-2 proteome is successfully sampled and presented by a diversity of HLA alleles. However, we found that HLA-B*46:01 had the fewest predicted binding peptides for SARS-CoV-2, suggesting individuals with this allele may be particularly vulnerable to COVID-19, as they were previously shown to be for SARS (Lin M, Tseng H-K, Trejaut JA, Lee H-L, Loo J-H, Chu C-C, Chen P-J, Su Y-W, Lim KH, Tsai Z-U, Lin R-Y, Lin R-S, Huang C-H. BMC Med Genet 4:9. 2003.). Conversely, we found that HLA-B*15:03 showed the greatest capacity to present highly conserved SARS-CoV-2 peptides that are shared among common human coronaviruses, suggesting it could enable cross-protective T-cell based immunity. Finally, we report global distributions of HLA types with potential epidemiological ramifications in the setting of the current pandemic.
        <b>
         IMPORTANCE
        </b>
        Individual genetic variation may help to explain different immune responses to a virus across a population. In particular, understanding how variation in HLA may affect the course of COVID-19 could help identify individuals at higher risk from the disease. HLA typing can be fast and inexpensive. Pairing HLA typing with COVID-19 testing where feasible could improve assessment of viral severity in the population. Following the development of a vaccine against SARS-CoV-2, the virus that causes COVID-19, individuals with high-risk HLA types could be prioritized for vaccination.
       </abstracttext>
       <copyrightinformation>
        Copyright Â© 2020 Nguyen et al.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Nguyen
        </lastname>
        <forename>
         Austin
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Computational Biology Program; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Biomedical Engineering; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         David
        </lastname>
        <forename>
         Julianne K
        </forename>
        <initials>
         JK
        </initials>
        <affiliationinfo>
         <affiliation>
          Computational Biology Program; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Biomedical Engineering; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Maden
        </lastname>
        <forename>
         Sean K
        </forename>
        <initials>
         SK
        </initials>
        <affiliationinfo>
         <affiliation>
          Computational Biology Program; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Biomedical Engineering; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wood
        </lastname>
        <forename>
         Mary A
        </forename>
        <initials>
         MA
        </initials>
        <affiliationinfo>
         <affiliation>
          Computational Biology Program; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Portland VA Research Foundation; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Weeder
        </lastname>
        <forename>
         Benjamin R
        </forename>
        <initials>
         BR
        </initials>
        <affiliationinfo>
         <affiliation>
          Computational Biology Program; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Biomedical Engineering; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Nellore
        </lastname>
        <forename>
         Abhinav
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Computational Biology Program; Oregon Health &amp; Science University; Portland, OR, 97239; USA nellore@ohsu.edu thompsre@ohsu.edu.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Biomedical Engineering; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Surgery; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Thompson
        </lastname>
        <forename>
         Reid F
        </forename>
        <initials>
         RF
        </initials>
        <affiliationinfo>
         <affiliation>
          Computational Biology Program; Oregon Health &amp; Science University; Portland, OR, 97239; USA nellore@ohsu.edu thompsre@ohsu.edu.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Biomedical Engineering; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Radiation Medicine; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Medical Informatics and Clinical Epidemiology; Oregon Health &amp; Science University; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Division of Hospital and Specialty Medicine; VA Portland Healthcare System; Portland, OR, 97239; USA.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        17
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       J Virol
      </medlineta>
      <nlmuniqueid>
       0113724
      </nlmuniqueid>
      <issnlinking>
       0022-538X
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        19
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        19
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        19
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32303592
      </articleid>
      <articleid idtype="pii">
       JVI.00510-20
      </articleid>
      <articleid idtype="doi">
       10.1128/JVI.00510-20
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="PubMed-not-MEDLINE">
     <pmid version="1">
      32300267
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       17
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Print">
        0941-8849
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         27
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          2018
         </year>
        </pubdate>
       </journalissue>
       <title>
        Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung
       </title>
       <isoabbreviation>
        Allergo J
       </isoabbreviation>
      </journal>
      <articletitle>
       Respiratory virus-induced heterologous immunity: Part of the problem or part of the solution?
      </articletitle>
      <pagination>
       <medlinepgn>
        28-45
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1007/s15007-018-1580-4
      </elocationid>
      <abstract>
       <abstracttext label="Purpose" nlmcategory="UNASSIGNED">
        To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infection, autoimmunity, allergy and transplant immunology. A better understanding of the mechanisms involved might ultimately open up possibilities for disease prevention, for example by vaccination.
       </abstracttext>
       <abstracttext label="Methods" nlmcategory="UNASSIGNED">
        A structured literature search was performed using Medline and PubMed to provide an overview of the current knowledge on respiratory-virus induced adaptive HI.
       </abstracttext>
       <abstracttext label="Results" nlmcategory="UNASSIGNED">
        In HI the immune response towards one antigen results in an alteration of the immune response towards a second antigen. We provide an overview of respiratory virus-induced HI, including viruses such as respiratory syncytial virus (RSV), rhinovirus (RV), coronavirus (CoV) and influenza virus (IV). We discuss T cell receptor (TCR) and humoral cross-reactivity as mechanisms of HI involving those respiratory viruses. Topics covered include HI between respiratory viruses as well as between respiratory viruses and other pathogens. Newly developed vaccines, which have the potential to provide protection against multiple virus strains are also discussed. Furthermore, respiratory viruses have been implicated in the development of autoimmune diseases, such as narcolepsy, Guillain-BarrÃ© syndrome, type 1 diabetes or myocarditis. Finally, we discuss the role of respiratory viruses in asthma and the hygiene hypothesis, and review our recent findings on HI between IV and allergens, which leads to protection from experimental asthma.
       </abstracttext>
       <abstracttext label="Conclusion" nlmcategory="UNASSIGNED">
        Respiratory-virus induced HI may have protective but also detrimental effects on the host. Respiratory viral infections contribute to asthma or autoimmune disease development, but on the other hand, a lack of microbial encounter is associated with an increasing number of allergic as well as autoimmune diseases. Future research might help identify the elements which determine a protective or detrimental outcome in HI-based mechanisms.
       </abstracttext>
       <copyrightinformation>
        Â© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Pusch
        </lastname>
        <forename>
         Emanuel
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Laboratory Medicine, Philipps University Marburg, BaldingerstraÃe, 35043 Marburg, Germany.
         </affiliation>
         <identifier source="GRID">
          grid.10253.35
         </identifier>
         <identifier source="ISNI">
          0000 0004 1936 9756
         </identifier>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Renz
        </lastname>
        <forename>
         Harald
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Laboratory Medicine, Philipps University Marburg, BaldingerstraÃe, 35043 Marburg, Germany.
         </affiliation>
         <identifier source="GRID">
          grid.10253.35
         </identifier>
         <identifier source="ISNI">
          0000 0004 1936 9756
         </identifier>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Skevaki
        </lastname>
        <forename>
         Chrysanthi
        </forename>
        <initials>
         C
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Laboratory Medicine, Philipps University Marburg, BaldingerstraÃe, 35043 Marburg, Germany.
         </affiliation>
         <identifier source="GRID">
          grid.10253.35
         </identifier>
         <identifier source="ISNI">
          0000 0004 1936 9756
         </identifier>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D016454">
        Review
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2018
       </year>
       <month>
        04
       </month>
       <day>
        26
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Germany
      </country>
      <medlineta>
       Allergo J
      </medlineta>
      <nlmuniqueid>
       9435413
      </nlmuniqueid>
      <issnlinking>
       0941-8849
      </issnlinking>
     </medlinejournalinfo>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       adaptive immunity
      </keyword>
      <keyword majortopicyn="N">
       asthma
      </keyword>
      <keyword majortopicyn="N">
       autoimmunity
      </keyword>
      <keyword majortopicyn="N">
       cross-reactivity
      </keyword>
      <keyword majortopicyn="N">
       respiratory virus
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2017
       </year>
       <month>
        12
       </month>
       <day>
        20
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2018
       </year>
       <month>
        02
       </month>
       <day>
        15
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2018
       </year>
       <month>
        1
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2018
       </year>
       <month>
        1
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32300267
      </articleid>
      <articleid idtype="doi">
       10.1007/s15007-018-1580-4
      </articleid>
      <articleid idtype="pii">
       1580
      </articleid>
      <articleid idtype="pmc">
       PMC7149200
      </articleid>
     </articleidlist>
     <?pmcsd ?>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32303077
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       17
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1098-8785
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          17
         </day>
        </pubdate>
       </journalissue>
       <title>
        American journal of perinatology
       </title>
       <isoabbreviation>
        Am J Perinatol
       </isoabbreviation>
      </journal>
      <articletitle>
       Considerations for Obstetric Care during the COVID-19 Pandemic.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1055/s-0040-1710051
      </elocationid>
      <abstract>
       <abstracttext>
        The novel coronavirus disease 2019 (COVID-19) is a growing pandemic that is impacting daily life across the globe. Though disease is often mild, in high-risk populations, severe disease often leads to intubation, intensive care admission (ICU) admission, and in many cases death. The implications for pregnancy remain largely unknown. Early data suggest that COVID-19 may not pose increased risk in the pregnant population. Vertical transmission has not been confirmed. Because no treatment, no vaccine and no herd immunity exist, social distancing is the best mechanism available to protect patients and health care workers from infection. This review will discuss what is known about the virus as it relates to pregnancy and then consider management considerations based on these data. KEY POINTS: Â· COVID-19 severity in pregnancy is unclear.. Â· Social distancing is the best protective mechanism.. Â· No clear evidence of vertical transmission exists.. Â· Mother/baby separation avoids transmission..
       </abstracttext>
       <copyrightinformation>
        Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author equalcontrib="N" validyn="Y">
        <lastname>
         Dotters-Katz
        </lastname>
        <forename>
         Sarah K
        </forename>
        <initials>
         SK
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
         </affiliation>
        </affiliationinfo>
       </author>
       <author equalcontrib="N" validyn="Y">
        <lastname>
         Hughes
        </lastname>
        <forename>
         Brenna L
        </forename>
        <initials>
         BL
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        17
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Am J Perinatol
      </medlineta>
      <nlmuniqueid>
       8405212
      </nlmuniqueid>
      <issnlinking>
       0735-1631
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <coistatement>
      None declared.
     </coistatement>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32303077
      </articleid>
      <articleid idtype="doi">
       10.1055/s-0040-1710051
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32302453
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       17
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1538-7836
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          17
         </day>
        </pubdate>
       </journalissue>
       <title>
        Journal of thrombosis and haemostasis : JTH
       </title>
       <isoabbreviation>
        J. Thromb. Haemost.
       </isoabbreviation>
      </journal>
      <articletitle>
       Thromboinflammation and the hypercoagulability of COVID-19.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1111/jth.14849
      </elocationid>
      <abstract>
       <abstracttext>
        The pathogenic coronavirus has been wreaking havoc worldwide since January. Infection with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral treatments are available. While many people with COVID-19 develop mild to moderate symptoms, some develop profound seemingly unchecked inflammatory responses leading to acute lung injury and hypoxemic respiratory failure, the most common cause for death.
       </abstracttext>
       <copyrightinformation>
        This article is protected by copyright. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Connors
        </lastname>
        <forename>
         Jean M
        </forename>
        <initials>
         JM
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, Hematology Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Levy
        </lastname>
        <forename>
         Jerrold H
        </forename>
        <initials>
         JH
        </initials>
        <affiliationinfo>
         <affiliation>
          Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC, USA.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        17
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       J Thromb Haemost
      </medlineta>
      <nlmuniqueid>
       101170508
      </nlmuniqueid>
      <issnlinking>
       1538-7836
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32302453
      </articleid>
      <articleid idtype="doi">
       10.1111/jth.14849
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32299202
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       17
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1303-6165
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          17
         </day>
        </pubdate>
       </journalissue>
       <title>
        Turkish journal of medical sciences
       </title>
       <isoabbreviation>
        Turk J Med Sci
       </isoabbreviation>
      </journal>
      <articletitle>
       COVID-19, immune system response, hyperinflammation and repurposing anti-rheumatic drugs.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.3906/sag-2004-168
      </elocationid>
      <abstract>
       <abstracttext>
        In the Wuhan province of China, in December 2019, the novel Coronavirus 2019 (COVID-19) has caused a severe involvement of the lower respiratory tract leading to an acute respiratory syndrome. Subsequently, coronavirus 2 (SARS-CoV-2) provoked a pandemic which is considered a life-threatening disease. The SARS-CoV-2, a family member of betacoronaviruses, possesses single single-stranded positive-sense RNA with typical structural proteins, involving the envelope, membrane, nucleocapsid and spike proteins that are responsible for the viral infectivity, and nonstructural proteins. The effectual host immune response including innate and adaptive immunity against SARS-Cov-2 seems crucial to control and resolve the viral infection. However, the severity and outcome of the COVID-19 might be associated with the excessive production of proinflammatory cytokines ?cytokine storm? leading to an acute respiratory distress syndrome. Regretfully, the exact pathophysiology and treatment, especially for the severe disease of COVID-19, is still uncertain. The results of preliminary studies have shown that immune-modulatory or immune-suppressive treatments such as hydroxychloroquine, interleukin (IL)-6 and IL-1 antagonists, commonly used in rheumatology, might be considered as treatment choices for COVID-19, particularly in severe lung disease. In this review, to better gain information about appropriate anti-inflammatory treatments, mostly used in rheumatology for COVID-19, we have focused the attention on the structural features of SARS-CoV-2, the host immune response against SARS-CoV-2 and its association with the cytokine storm.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Tufan
        </lastname>
        <forename>
         Abdurrahman
        </forename>
        <initials>
         A
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         AvanoÄlu GÃ¼ler
        </lastname>
        <forename>
         Aslihan
        </forename>
        <initials>
         A
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         Matucci-Cerinic
        </lastname>
        <forename>
         Marco
        </forename>
        <initials>
         M
        </initials>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        17
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Turkey
      </country>
      <medlineta>
       Turk J Med Sci
      </medlineta>
      <nlmuniqueid>
       9441758
      </nlmuniqueid>
      <issnlinking>
       1300-0144
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       anti-inflammatory
      </keyword>
      <keyword majortopicyn="N">
       cytokine storm
      </keyword>
      <keyword majortopicyn="N">
       inflammation
      </keyword>
      <keyword majortopicyn="N">
       rheumatology
      </keyword>
      <keyword majortopicyn="N">
       treatment
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        15
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        16
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32299202
      </articleid>
      <articleid idtype="doi">
       10.3906/sag-2004-168
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32298218
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        2164-554X
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          16
         </day>
        </pubdate>
       </journalissue>
       <title>
        Human vaccines &amp; immunotherapeutics
       </title>
       <isoabbreviation>
        Hum Vaccin Immunother
       </isoabbreviation>
      </journal>
      <articletitle>
       Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19.
      </articletitle>
      <pagination>
       <medlinepgn>
        1-4
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1080/21645515.2020.1740560
      </elocationid>
      <abstract>
       <abstracttext>
        A SARS-CoV receptor-binding domain (RBD) recombinant protein was developed and manufactured under current good manufacturing practices in 2016. The protein, known as RBD219-N1 when formulated on AlhydrogelÂ®, induced high-level neutralizing antibodies and protective immunity with minimal immunopathology in mice after a homologous virus challenge with SARS-CoV (MA15 strain). We examined published evidence in support of whether the SARS-CoV RBD219-N1 could be repurposed as a heterologous vaccine against Coronavirus Infectious Disease (COVID)-19. Our findings include evidence that convalescent serum from SARS-CoV patients can neutralize SARS-CoV-2. Additionally, a review of published studies using monoclonal antibodies (mAbs) raised against SARS-CoV RBD and that neutralizes the SARS-CoV virus
        <i>
         in vitro
        </i>
        finds that some of these mAbs bind to the receptor-binding motif (RBM) within the RBD, while others bind to domains outside this region within RBD. This information is relevant and supports the possibility of developing a heterologous SARS-CoV RBD vaccine against COVID-19, especially due to the finding that the overall high amino acid similarity (82%) between SARS-CoV and SARS-CoV-2 spike and RBD domains is not reflected in RBM amino acid similarity (59%). However, the high sequence similarity (94%) in the region outside of RBM offers the potential of conserved neutralizing epitopes between both viruses.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Chen
        </lastname>
        <forename>
         Wen-Hsiang
        </forename>
        <initials>
         WH
        </initials>
        <affiliationinfo>
         <affiliation>
          Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hotez
        </lastname>
        <forename>
         Peter J
        </forename>
        <initials>
         PJ
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0001-8770-1042
        </identifier>
        <affiliationinfo>
         <affiliation>
          Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Molecular Virology &amp; Microbiology, Baylor College of Medicine, Houston, TX, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bottazzi
        </lastname>
        <forename>
         Maria Elena
        </forename>
        <initials>
         ME
        </initials>
        <affiliationinfo>
         <affiliation>
          Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Molecular Virology &amp; Microbiology, Baylor College of Medicine, Houston, TX, USA.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        16
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Hum Vaccin Immunother
      </medlineta>
      <nlmuniqueid>
       101572652
      </nlmuniqueid>
      <issnlinking>
       2164-5515
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       Heterologous vaccine
      </keyword>
      <keyword majortopicyn="N">
       SARS
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
      <keyword majortopicyn="N">
       coronavirus
      </keyword>
      <keyword majortopicyn="N">
       receptor-binding domain
      </keyword>
      <keyword majortopicyn="N">
       subunit vaccine
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32298218
      </articleid>
      <articleid idtype="doi">
       10.1080/21645515.2020.1740560
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32296837
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1537-6613
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          15
         </day>
        </pubdate>
       </journalissue>
       <title>
        The Journal of infectious diseases
       </title>
       <isoabbreviation>
        J. Infect. Dis.
       </isoabbreviation>
      </journal>
      <articletitle>
       Epidemiology of seasonal coronaviruses: Establishing the context for COVID-19 emergence.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       jiaa185
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1093/infdis/jiaa185
      </elocationid>
      <abstract>
       <abstracttext>
        Public health preparedness for coronavirus disease 2019 (COVID-19) is challenging in the absence of setting-specific epidemiological data. Here we describe the epidemiology of seasonal coronaviruses (sCoVs) and other cocirculating viruses in the West of Scotland, UK. We analyzed routine diagnostic data for &gt;70,000 episodes of respiratory illness tested molecularly for multiple respiratory viruses between 2005 and 2017. Statistical associations with patient age and sex differed between CoV-229E, CoV-OC43 and CoV-NL63. Furthermore, the timing and magnitude of sCoV outbreaks did not occur concurrently and coinfections were not reported. With respect to other cocirculating respiratory viruses, we found evidence of positive, rather than negative, interactions with sCoVs. These findings highlight the importance of considering cocirculating viruses in the differential diagnosis of COVID-19. Further work is needed to establish the occurrence/degree of cross-protective immunity conferred across sCoVs and with COVID-19, as well as the role of viral coinfection in COVID-19 disease severity.
       </abstracttext>
       <copyrightinformation>
        Â© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Nickbakhsh
        </lastname>
        <forename>
         Sema
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ho
        </lastname>
        <forename>
         Antonia
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Marques
        </lastname>
        <forename>
         Diogo F P
        </forename>
        <initials>
         DFP
        </initials>
        <affiliationinfo>
         <affiliation>
          Health Protection Scotland, NHS National Services Scotland, G2 6QE Glasgow, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         McMenamin
        </lastname>
        <forename>
         Jim
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Health Protection Scotland, NHS National Services Scotland, G2 6QE Glasgow, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gunson
        </lastname>
        <forename>
         Rory N
        </forename>
        <initials>
         RN
        </initials>
        <affiliationinfo>
         <affiliation>
          West of Scotland Specialist Virology Centre, NHS Greater Glasgow and Clyde, Glasgow, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Murcia
        </lastname>
        <forename>
         Pablo R
        </forename>
        <initials>
         PR
        </initials>
        <affiliationinfo>
         <affiliation>
          MRC-University of Glasgow Centre for Virus Research, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        15
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       J Infect Dis
      </medlineta>
      <nlmuniqueid>
       0413675
      </nlmuniqueid>
      <issnlinking>
       0022-1899
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      AIM
     </citationsubset>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Acute respiratory infections
      </keyword>
      <keyword majortopicyn="N">
       Coinfection
      </keyword>
      <keyword majortopicyn="N">
       Disease surveillance
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
      <keyword majortopicyn="N">
       Virus-virus interactions
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        18
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32296837
      </articleid>
      <articleid idtype="pii">
       5820656
      </articleid>
      <articleid idtype="doi">
       10.1093/infdis/jiaa185
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32295922
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1098-5514
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          15
         </day>
        </pubdate>
       </journalissue>
       <title>
        Journal of virology
       </title>
       <isoabbreviation>
        J. Virol.
       </isoabbreviation>
      </journal>
      <articletitle>
       Middle East respiratory syndrome coronavirus nucleocapsid protein suppresses type I and type III interferon induction by targeting RIG-I signaling.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       JVI.00099-20
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1128/JVI.00099-20
      </elocationid>
      <abstract>
       <abstracttext>
        Type I and type III interferons (IFNs) are the frontlines of antiviral defense mechanism that trigger hundreds of downstream antiviral genes. In this study, we observed that MERS-CoV nucleocapsid (N) protein suppresses type I and III IFN gene expression. The N protein suppresses Sendai virus-induced IFN-Î² and IFN-Î»1 by reducing their promoter activity and mRNA levels as well as downstream IFN stimulated genes (ISGs). Retinoic acid-inducible gene-I (RIG-I) is known to recognize viral RNA and induce IFN expression through tripartite motif-containing protein 25 (TRIM25)-mediated ubiquitination of RIG-I caspase activation and recruitment domains (CARDs). We discovered that MERS-CoV N protein suppresses RIG-I-CARD-, but not MDA5-CARD-induced IFN-Î² and IFN-Î»1 promoter activity. By interacting with TRIM25, N protein impedes RIG-I ubiquitination and activation and inhibits the phosphorylation of transcription factors IFN-regulatory factor 3 (IRF3) and NF-ÎºB that are known to be important for IFN gene activation. By employing recombinant Sindbis virus-EGFP replication system, we showed that viral N protein downregulated the production of not only IFN mRNA but also bioactive IFN proteins. Taken together, MERS-CoV N protein functions as an IFN antagonist. It suppresses RIG-I-induced type I and type III IFN production by interfering with TRIM25-mediated RIG-I ubiquitination. Our study sheds light on the pathogenic mechanism of how MERS-CoV causes disease.
        <b>
         IMPORTANCE
        </b>
        MERS-CoV causes death of about 35% of patients. Published studies showed that some coronaviruses are capable of suppressing interferon (IFN) expression in the early phase of infection and MERS-CoV proteins can modulate host immune response. In this study, we demonstrated that MERS-CoV nucleocapsid (N) protein suppresses the production of both type I and type III IFNs via sequestering TRIM25, an E3 ubiquitin ligase that is essential for activating RIG-I signaling pathway. Ectopic expression of TRIM25 rescues the suppressive effect of the N protein. In addition, the C-terminal domain of the viral N protein plays a pivotal role in the suppression of IFN-Î² promoter activity. Our findings reveal how MERS-CoV evades innate immunity and provide insights into the interplay between host immune response and viral pathogenicity.
       </abstracttext>
       <copyrightinformation>
        Copyright Â© 2020 American Society for Microbiology.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Chang
        </lastname>
        <forename>
         Chi-You
        </forename>
        <initials>
         CY
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Liu
        </lastname>
        <forename>
         Helene Minyi
        </forename>
        <initials>
         HM
        </initials>
        <identifier source="ORCID">
         http://orcid.org/0000-0003-4837-5373
        </identifier>
        <affiliationinfo>
         <affiliation>
          Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chang
        </lastname>
        <forename>
         Ming-Fu
        </forename>
        <initials>
         MF
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine, Taipei, Taiwan mfchang@ntu.edu.tw.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chang
        </lastname>
        <forename>
         Shin C
        </forename>
        <initials>
         SC
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan scchang093@ntu.edu.tw.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        15
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       J Virol
      </medlineta>
      <nlmuniqueid>
       0113724
      </nlmuniqueid>
      <issnlinking>
       0022-538X
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32295922
      </articleid>
      <articleid idtype="pii">
       JVI.00099-20
      </articleid>
      <articleid idtype="doi">
       10.1128/JVI.00099-20
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="PubMed-not-MEDLINE">
     <pmid version="1">
      32295153
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Electronic">
      <journal>
       <issn issntype="Print">
        2076-393X
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         8
        </volume>
        <issue>
         2
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          14
         </day>
        </pubdate>
       </journalissue>
       <title>
        Vaccines
       </title>
       <isoabbreviation>
        Vaccines (Basel)
       </isoabbreviation>
      </journal>
      <articletitle>
       What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       E183
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.3390/vaccines8020183
      </elocationid>
      <abstract>
       <abstracttext>
        The emergence of new pathogenic viral strains is a constant threat to global health, with the new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS-CoV-2 virus has quickly spread around the globe. This pandemic demands rapid development of drugs and vaccines. Plant-based vaccines are a technology with proven viability, which have led to promising results for candidates evaluated at the clinical level, meaning this technology could contribute towards the fight against COVID-19. Herein, a perspective in how plant-based vaccines can be developed against COVID-19 is presented. Injectable vaccines could be generated by using transient expression systems, which offer the highest protein yields and are already adopted at the industrial level to produce VLPs-vaccines and other biopharmaceuticals under GMPC-processes. Stably-transformed plants are another option, but this approach requires more time for the development of antigen-producing lines. Nonetheless, this approach offers the possibility of developing oral vaccines in which the plant cell could act as the antigen delivery agent. Therefore, this is the most attractive approach in terms of cost, easy delivery, and mucosal immunity induction. The development of multiepitope, rationally-designed vaccines is also discussed regarding the experience gained in expression of chimeric immunogenic proteins in plant systems.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Rosales-Mendoza
        </lastname>
        <forename>
         Sergio
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Facultad de Ciencias QuÃ­micas, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Dr. Manuel Nava 6, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          SecciÃ³n de BiotecnologÃ­a, Centro de InvestigaciÃ³n en Ciencias de la Salud y Biomedicina, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Sierra Leona 550, Lomas 2Âª SecciÃ³n, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         MÃ¡rquez-Escobar
        </lastname>
        <forename>
         VerÃ³nica A
        </forename>
        <initials>
         VA
        </initials>
        <affiliationinfo>
         <affiliation>
          Facultad de Ciencias QuÃ­micas, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Dr. Manuel Nava 6, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          SecciÃ³n de BiotecnologÃ­a, Centro de InvestigaciÃ³n en Ciencias de la Salud y Biomedicina, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Sierra Leona 550, Lomas 2Âª SecciÃ³n, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         GonzÃ¡lez-Ortega
        </lastname>
        <forename>
         Omar
        </forename>
        <initials>
         O
        </initials>
        <identifier source="ORCID">
         0000-0002-5878-8078
        </identifier>
        <affiliationinfo>
         <affiliation>
          Facultad de Ciencias QuÃ­micas, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Dr. Manuel Nava 6, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Nieto-GÃ³mez
        </lastname>
        <forename>
         Ricardo
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Facultad de Ciencias QuÃ­micas, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Dr. Manuel Nava 6, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          SecciÃ³n de BiotecnologÃ­a, Centro de InvestigaciÃ³n en Ciencias de la Salud y Biomedicina, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Sierra Leona 550, Lomas 2Âª SecciÃ³n, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         ArÃ©valo-Villalobos
        </lastname>
        <forename>
         Jaime I
        </forename>
        <initials>
         JI
        </initials>
        <affiliationinfo>
         <affiliation>
          Facultad de Ciencias QuÃ­micas, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Dr. Manuel Nava 6, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          SecciÃ³n de BiotecnologÃ­a, Centro de InvestigaciÃ³n en Ciencias de la Salud y Biomedicina, Universidad AutÃ³noma de San Luis PotosÃ­, Av. Sierra Leona 550, Lomas 2Âª SecciÃ³n, San Luis PotosÃ­ 78210, Mexico.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         PRODEP-2020
        </grantid>
        <agency>
         Consejo Nacional de Ciencia y TecnologÃ­a
        </agency>
        <country>
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D016454">
        Review
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        14
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Switzerland
      </country>
      <medlineta>
       Vaccines (Basel)
      </medlineta>
      <nlmuniqueid>
       101629355
      </nlmuniqueid>
      <issnlinking>
       2076-393X
      </issnlinking>
     </medlinejournalinfo>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       epitope-based vaccine
      </keyword>
      <keyword majortopicyn="N">
       molecular farming
      </keyword>
      <keyword majortopicyn="N">
       mucosal immunization
      </keyword>
      <keyword majortopicyn="N">
       multiepitope vaccine
      </keyword>
      <keyword majortopicyn="N">
       oral vaccines
      </keyword>
      <keyword majortopicyn="N">
       zoonosis
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        27
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="revised">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        08
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        09
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      epublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32295153
      </articleid>
      <articleid idtype="pii">
       vaccines8020183
      </articleid>
      <articleid idtype="doi">
       10.3390/vaccines8020183
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32293833
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       15
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1303-6165
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          15
         </day>
        </pubdate>
       </journalissue>
       <title>
        Turkish journal of medical sciences
       </title>
       <isoabbreviation>
        Turk J Med Sci
       </isoabbreviation>
      </journal>
      <articletitle>
       EMERGING AND REEMERGING RESPIRATORY VIRAL INFECTIONS UP TO COVID-19.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.3906/sag-2004-126
      </elocationid>
      <abstract>
       <abstracttext>
        Infectious diseases remain as the significant causes of human and animal morbidity and mortality, leading to extensive outbreaks and epidemics. Acute respiratory viral diseases claim over four million deaths and cause millions of hospitalizations in developing countries every year. Emerging viruses, especially the RNA viruses, are more pathogenic since most people have no herd immunity. The RNA viruses can adapt to the rapidly changing global and local environment due to the high error rate of their polymerases that replicate their genomes. Currently, Coronavirus disease 2019 (COVID-19) is determined as an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified in 2019 in Wuhan. Herein we discuss emerging and reemerging respiratory viral infections till to SARS-CoV-2.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Ãelik
        </lastname>
        <forename>
         Ilhami
        </forename>
        <initials>
         I
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         SaatÃ§i
        </lastname>
        <forename>
         Esma
        </forename>
        <initials>
         E
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         EyÃ¼boÄlu
        </lastname>
        <forename>
         AyÅegÃ¼l FÃ¼sun
        </forename>
        <initials>
         AF
        </initials>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        15
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Turkey
      </country>
      <medlineta>
       Turk J Med Sci
      </medlineta>
      <nlmuniqueid>
       9441758
      </nlmuniqueid>
      <issnlinking>
       1300-0144
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Covid-19
      </keyword>
      <keyword majortopicyn="N">
       Emerging
      </keyword>
      <keyword majortopicyn="N">
       Reemerging
      </keyword>
      <keyword majortopicyn="N">
       Respiratory virus
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        12
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        14
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32293833
      </articleid>
      <articleid idtype="doi">
       10.3906/sag-2004-126
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32293098
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       15
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        2326-5205
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          15
         </day>
        </pubdate>
       </journalissue>
       <title>
        Arthritis &amp; rheumatology (Hoboken, N.J.)
       </title>
      </journal>
      <articletitle>
       On the alert for cytokine storm: Immunopathology in COVID-19.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1002/art.41285
      </elocationid>
      <abstract>
       <abstracttext>
        Coronavirus disease 2019 (COVID-19) is sweeping across the globe. Most patients have mild to moderate symptoms, but a subgroup will become severely ill. Sepsis, respiratory failure, and acute respiratory distress syndrome (ARDS) are common complications of the disease.(1) Factors associated with ICU admission and death include older age, comorbid conditions, elevated body mass index, lymphopenia, and elevated transaminases, LDH, D-dimer, ferritin, and soluble IL-2 receptor (sIL-2R).(1-4).
       </abstracttext>
       <copyrightinformation>
        This article is protected by copyright. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Henderson
        </lastname>
        <forename>
         Lauren A
        </forename>
        <initials>
         LA
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Canna
        </lastname>
        <forename>
         Scott W
        </forename>
        <initials>
         SW
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Immunology, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Schulert
        </lastname>
        <forename>
         Grant S
        </forename>
        <initials>
         GS
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Rheumatology, Cincinnati Children's Hospital Medical Center and , Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Volpi
        </lastname>
        <forename>
         Stefano
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Center for Autoinflammatory Diseases and Immunodeficiency, IRCCS Istituto Giannina Gaslini and UniversitÃ  degli Studi di Genova, Genova, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lee
        </lastname>
        <forename>
         Pui Y
        </forename>
        <initials>
         PY
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kernan
        </lastname>
        <forename>
         Kate F
        </forename>
        <initials>
         KF
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pediatric Critical Care Medicine, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Caricchio
        </lastname>
        <forename>
         Roberto
        </forename>
        <initials>
         R
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0002-1379-1118
        </identifier>
        <affiliationinfo>
         <affiliation>
          Division of Rheumatology, Temple University Hospital, Lewis Katz School of Medicine, Philadelphia, PA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Mahmud
        </lastname>
        <forename>
         Shawn
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Pediatric Rheumatology, University of Minnesota, Medical Center, University of Minnesota School of Medicine, Minneapolis, MN, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hazen
        </lastname>
        <forename>
         Melissa M
        </forename>
        <initials>
         MM
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Halyabar
        </lastname>
        <forename>
         Olha
        </forename>
        <initials>
         O
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hoyt
        </lastname>
        <forename>
         Kacie J
        </forename>
        <initials>
         KJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Han
        </lastname>
        <forename>
         Joseph
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Icahn School of Medicine at Mount Sinai, New York, NY, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Grom
        </lastname>
        <forename>
         Alexei A
        </forename>
        <initials>
         AA
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Rheumatology, Cincinnati Children's Hospital Medical Center and , Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gattorno
        </lastname>
        <forename>
         Marco
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Center for Autoinflammatory Diseases and Immunodeficiency, IRCCS Istituto Giannina Gaslini and UniversitÃ  degli Studi di Genova, Genova, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ravelli
        </lastname>
        <forename>
         Angelo
        </forename>
        <initials>
         A
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0001-9658-0385
        </identifier>
        <affiliationinfo>
         <affiliation>
          Clinica Pediatrica e Reumatologia, IRCCS Istituto Giannina Gaslini and UniversitÃ  degli Studi di Genova, Genova, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         de Benedetti
        </lastname>
        <forename>
         Fabrizio
        </forename>
        <initials>
         F
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Rheumatology, Ospedale Pediatrico Bambino GesÃ¹, Rome, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Behrens
        </lastname>
        <forename>
         Edward M
        </forename>
        <initials>
         EM
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Rheumatology, Children's Hospital of Philadelphia, Perelman School of Medicine at the , University of Pennsylvania, Philadelphia, PA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cron
        </lastname>
        <forename>
         Randy Q
        </forename>
        <initials>
         RQ
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Pediatric Rheumatology, Children's of Alabama, University of Alabama at Birmingham, Birmingham, AL, England.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Nigrovic
        </lastname>
        <forename>
         Peter A
        </forename>
        <initials>
         PA
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        15
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Arthritis Rheumatol
      </medlineta>
      <nlmuniqueid>
       101623795
      </nlmuniqueid>
      <issnlinking>
       2326-5191
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      AIM
     </citationsubset>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32293098
      </articleid>
      <articleid idtype="doi">
       10.1002/art.41285
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="PubMed-not-MEDLINE">
     <pmid version="1">
      32292881
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       18
      </day>
     </daterevised>
     <article pubmodel="Electronic">
      <journal>
       <issn issntype="Electronic">
        2523-0204
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         4
        </volume>
        <issue>
         4
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          02
         </day>
        </pubdate>
       </journalissue>
       <title>
        Cell stress
       </title>
       <isoabbreviation>
        Cell Stress
       </isoabbreviation>
      </journal>
      <articletitle>
       Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses.
      </articletitle>
      <pagination>
       <medlinepgn>
        66-75
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.15698/cst2020.04.216
      </elocationid>
      <abstract>
       <abstracttext>
        Coronaviruses (CoVs) are a large family of enveloped, positive-strand RNA viruses. Four human CoVs (HCoVs), the non-severe acute respiratory syndrome (SARS)-like HCoVs (namely HCoV 229E, NL63, OC43, and HKU1), are globally endemic and account for a substantial fraction of upper respiratory tract infections. Non-SARS-like CoV can occasionally produce severe diseases in frail subjects but do not cause any major (fatal) epidemics. In contrast, SARS like CoVs (namely SARS-CoV and Middle-East respiratory syndrome coronavirus, MERS-CoV) can cause intense short-lived fatal outbreaks. The current epidemic caused by the highly contagious SARS-CoV-2 and its rapid spread globally is of major concern. There is scanty knowledge on the actual pandemic potential of this new SARS-like virus. It might be speculated that SARS-CoV-2 epidemic is grossly underdiagnosed and that the infection is silently spreading across the globe with two consequences: (i) clusters of severe infections among frail subjects could haphazardly occur linked to unrecognized index cases; (ii) the current epidemic could naturally fall into a low-level endemic phase when a significant number of subjects will have developed immunity. Understanding the role of paucisymptomatic subjects and stratifying patients according to the risk of developing severe clinical presentations is pivotal for implementing reasonable measures to contain the infection and to reduce its mortality. Whilst the future evolution of this epidemic remains unpredictable, classic public health strategies must follow rational patterns. The emergence of yet another global epidemic underscores the permanent challenges that infectious diseases pose and underscores the need for global cooperation and preparedness, even during inter-epidemic periods.
       </abstracttext>
       <copyrightinformation>
        Copyright: Â© 2020 Raoult et al.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Raoult
        </lastname>
        <forename>
         Didier
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Aix-Marseille Univ., Institut de Recherche pour le DÃ©veloppement (IRD), Assistance Publique - HÃ´pitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 Marseille, France; IHU MÃ©diterranÃ©e Infection, Marseille, France.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zumla
        </lastname>
        <forename>
         Alimuddin
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Infection and Immunity, Center for Clinical Microbiology, University College London, London, UK.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          The National Institute of Health Research Biomedical Research Centre at UCL Hospitals, London, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Locatelli
        </lastname>
        <forename>
         Franco
        </forename>
        <initials>
         F
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pediatric Hematology and Oncology IRCCS Ospedale Pediatrico Bambino GesÃ¹, Rome, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ippolito
        </lastname>
        <forename>
         Giuseppe
        </forename>
        <initials>
         G
        </initials>
        <affiliationinfo>
         <affiliation>
          National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kroemer
        </lastname>
        <forename>
         Guido
        </forename>
        <initials>
         G
        </initials>
        <affiliationinfo>
         <affiliation>
          Centre de Recherche des Cordeliers, Equipe labellisÃ©e par la Ligue contre le cancer, UniversitÃ© de Paris, Sorbonne UniversitÃ©, INSERM U1138, Institut Universitaire de France, Paris, France.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Villejuif, France.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          PÃ´le de Biologie, HÃ´pital EuropÃ©en Georges Pompidou, AP-HP, Paris, France.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016421">
        Editorial
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        02
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Austria
      </country>
      <medlineta>
       Cell Stress
      </medlineta>
      <nlmuniqueid>
       101718867
      </nlmuniqueid>
      <issnlinking>
       2523-0204
      </issnlinking>
     </medlinejournalinfo>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       Coronavirus
      </keyword>
      <keyword majortopicyn="N">
       MERS-CoV
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV
      </keyword>
      <keyword majortopicyn="N">
       epidemiology
      </keyword>
      <keyword majortopicyn="N">
       immunology
      </keyword>
      <keyword majortopicyn="N">
       sARS-CoV-2
      </keyword>
     </keywordlist>
     <coistatement>
      Conflict of interest: The authors declare that they have no relevant conflict of interest.
     </coistatement>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      epublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32292881
      </articleid>
      <articleid idtype="doi">
       10.15698/cst2020.04.216
      </articleid>
      <articleid idtype="pii">
       CST0270E115
      </articleid>
      <articleid idtype="pmc">
       PMC7146059
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Pathog Glob Health. 2016 May;110(3):113-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27195607
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Microbes Infect. 2020 Mar;22(2):72-73
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32092539
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2018 May 5;217(11):1728-1739
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29741740
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Feb 24;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32091533
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Thorac Dis. 2013 Aug;5 Suppl 2:S103-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23977429
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Int J Immunogenet. 2008 Feb;35(1):69-74
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18186801
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virology. 2007 Oct 25;367(2):367-74
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17631932
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Hong Kong Med J. 2010;16(5 Suppl 4):29-33
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20864745
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        BMC Infect Dis. 2016 Oct 24;16(1):597
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27776489
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Virol. 2018 Apr;101:52-56
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29427907
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Curr Opin Pulm Med. 2014 May;20(3):233-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24626235
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS One. 2018 Jan 29;13(1):e0191789
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29377913
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        New Microbiol. 2016 Oct;39(4):287-289
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28004846
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Vaccine. 2016 Apr 12;34(17):2008-14
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26954467
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2020 Feb 28;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32109013
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Med Mal Infect. 2018 Mar;48(2):141-144
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29402475
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        BMJ. 2020 Feb 25;368:m751
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32098875
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2012 Dec;12(12):914-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23316491
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cell Discov. 2020 Feb 24;6:11
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32133153
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2015 May;15(5):495-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25863563
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cell Res. 2020 Mar;30(3):269-271
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32020029
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 17;41(2):145-151
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32064853
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Virol. 2016 Dec 16;91(1):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27795435
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Transl Med. 2019 Dec 4;11(521):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31801887
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 2006 Jun;44(6):2063-71
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16757599
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Virol. 2019 Nov 26;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31769524
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Open Forum Infect Dis. 2017 Mar 25;4(2):ofx052
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28616442
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2014 Aug 28;371(9):828-35
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25162889
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Respir Med. 2020 Mar;8(3):230-231
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32146924
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Allergy. 2020 Feb 19;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32077115
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2015 May;15(5):559-64
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25863564
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Biosci Trends. 2020 Mar 16;14(1):72-73
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32074550
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Immunol. 2017 Aug 4;2(14):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28778905
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2012 Nov 8;367(19):1814-20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23075143
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        New Microbiol. 2016 Apr;39(2):83-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27196544
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2003 Nov 27;426(6965):450-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14647384
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Semin Immunopathol. 2016 Jul;38(4):471-82
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26965109
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2018 Oct;24(10):1964-1966
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30226169
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Immunity. 2016 Jun 21;44(6):1379-91
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27287409
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Health Sci Rep. 2018 Jul 18;1(8):e59
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30623094
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Viruses. 2020 Feb 22;12(2):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32098422
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Infect Dis Clin North Am. 2019 Dec;33(4):869-889
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31668196
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Front Immunol. 2019 Sep 06;10:2075
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31552032
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virol J. 2016 Feb 01;13:18
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26833249
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Immunol Res. 2019 Feb 18;2019:1386740
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30906787
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2018 Aug;18(8):e217-e227
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29680581
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        East Mediterr Health J. 2013;19 Suppl 1:S12-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23888790
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Vaccine Immunol. 2008 Dec;15(12):1805-10
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18945884
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Public Health. 2017 Mar - Apr;10(2):191-194
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27140697
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Feb 7;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32031570
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Viral Immunol. 2011 Oct;24(5):421-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21958371
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virol Sin. 2014 Apr;29(2):128-30
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24643938
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Int J Antimicrob Agents. 2020 Mar;55(3):105923
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32070753
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Rev Microbiol. 2016 Aug;14(8):523-34
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27344959
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Travel Med. 2020 Feb 28;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32109273
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS One. 2014 Jul 31;9(7):e99782
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25080241
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Viruses. 2018 Aug 28;10(9):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30154345
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Med. 2005 Aug;11(8):875-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16007097
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2015 Feb 26;372(9):846-54
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25714162
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Feb 21;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32083643
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2014 Jun 26;370(26):2499-505
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24896817
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Adv Immunol. 1993;53:157-216
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         8512035
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS One. 2014 Feb 03;9(2):e86448
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24498274
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Microbes Infect. 2019;8(1):339-352
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30866787
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Respir Med. 2015 Jul;3(7):509-10
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26050550
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 Dec 18;349(25):2431-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14681510
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Jan 23;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31971553
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2015 Sep 5;386(9997):995-1007
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26049252
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Eur J Pediatr. 2008 Dec;167(12):1427-34
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18335238
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):363-369
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29214503
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32291968
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       15
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1759-7714
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          14
         </day>
        </pubdate>
       </journalissue>
       <title>
        Thoracic cancer
       </title>
       <isoabbreviation>
        Thorac Cancer
       </isoabbreviation>
      </journal>
      <articletitle>
       Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1111/1759-7714.13424
      </elocationid>
      <abstract>
       <abstracttext>
        Since its outbreak in December 2019 in China, the novel coronavirus disease (COVID-19) has rapidly spread and affected several countries. It has resulted in a difficult situation for cancer patients owing to the risks of the epidemic situation outbreak as well as cancer. Patients with cancer are more likely than the general population to contract COVID-19 because of the systemic immunosuppressive status caused by malignant diseases or anticancer treatment. Lung cancer has the highest morbidity and mortality in China and the world. Most patients with lung cancer are smokers with poor underlying lung conditions and low immunity, thus it is vital to protect them from epidemic diseases during cancer treatment. It is necessary to provide individualized medical treatment and management of treatment-related adverse events for patients with lung cancer based on patients' conditions and regional epidemic patterns.
       </abstracttext>
       <copyrightinformation>
        Â© 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley &amp; Sons Australia, Ltd.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Zhao
        </lastname>
        <forename>
         Zhe
        </forename>
        <initials>
         Z
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bai
        </lastname>
        <forename>
         Hua
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Duan
        </lastname>
        <forename>
         Jianchun
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Jie
        </forename>
        <initials>
         J
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0002-5602-0487
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <agency>
         Ministry of Education
        </agency>
        <country>
        </country>
       </grant>
       <grant>
        <agency>
         Innovation Fund
        </agency>
        <country>
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        14
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Singapore
      </country>
      <medlineta>
       Thorac Cancer
      </medlineta>
      <nlmuniqueid>
       101531441
      </nlmuniqueid>
      <issnlinking>
       1759-7706
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       lung neoplasms
      </keyword>
      <keyword majortopicyn="N">
       therapeutics
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        16
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        17
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32291968
      </articleid>
      <articleid idtype="doi">
       10.1111/1759-7714.13424
      </articleid>
     </articleidlist>
     <referencelist>
      <title>
       References
      </title>
      <reference>
       <citation>
        Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55: 105924.
       </citation>
      </reference>
      <reference>
       <citation>
        Jin YH, Cai L, Cheng ZS et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020; 7: 4.
       </citation>
      </reference>
      <reference>
       <citation>
        Liang W, Guan W, Chen R et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol 2020; 21: 335-7.
       </citation>
      </reference>
      <reference>
       <citation>
        Yuan JH, Li QS. Therape uticprocess and doctor-patient protection measures of patients undergoing radiotherapy for tumors in the epidemic of novel coronavirus pneumonia. J Mod Oncol 2020; 28: 1-3.
       </citation>
      </reference>
      <reference>
       <citation>
        Salazar MC, Rosen JE, Wang Z et al. Association of delayed adjuvant chemotherapy with survival after lung cancer surgery. JAMA Oncol 2017; 3: 610-9.
       </citation>
      </reference>
      <reference>
       <citation>
        Zhong WZ, Wang Q, Mao WM et al. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): A randomised, open-label, phase 3 study. Lancet Oncol 2018; 19: 139-48.
       </citation>
      </reference>
      <reference>
       <citation>
        da Cunha SG, Shepherd FA, Tsao MS. EGFR mutations and lung cancer. Annu Rev Pathol 2011; 6: 49-69.
       </citation>
      </reference>
      <reference>
       <citation>
        Sgambato A, Casaluce F, Maione P, Gridelli C. Targeted therapies in non-small cell lung cancer: A focus on ALK/ROS1 tyrosine kinase inhibitors. Expert Rev Anticancer Ther 2018; 18: 71-80.
       </citation>
      </reference>
      <reference>
       <citation>
        Li JX, Huang JM, Jiang ZB et al. Current clinical Progress of PD-1/PD-L1 immunotherapy and potential combination treatment in non-small cell lung cancer. Integr Cancer Ther 2019; 18:1534735419890020.
       </citation>
      </reference>
      <reference>
       <citation>
        Wargo JA, Reuben A, Cooper ZA, Oh KS, Sullivan RJ. Immune effects of chemotherapy, radiation, and targeted therapy and opportunities for combination with immunotherapy. Semin Oncol 2015; 42: 601-16.
       </citation>
      </reference>
      <reference>
       <citation>
        Liu M, Wang X, Li H et al. The effect of apatinib combined with chemotherapy or targeted therapy on non-small cell lung cancer in vitro and vivo. Thorac Cancer 2019; 10: 1868-78.
       </citation>
      </reference>
      <reference>
       <citation>
        Wang Y, Xie S, He B. Effect of EGFR gene polymorphism on efficacy of chemotherapy combined with targeted therapy for non-small cell lung cancer in Chinese patients. Am J Cancer Res 2019; 9: 619-27.
       </citation>
      </reference>
      <reference>
       <citation>
        Qiang H, Chang Q, Xu J et al. New advances in antiangiogenic combination therapeutic strategies for advanced non-small cell lung cancer. J Cancer Res Clin Oncol 2020; 146: 631-45.
       </citation>
      </reference>
      <reference>
       <citation>
        Sun X, Roudi R, Dai T et al. Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: A PRISMA systematic review and meta-analysis. BMC Cancer 2019; 19: 558.
       </citation>
      </reference>
      <reference>
       <citation>
        Hoffner B, Leighl NB, Davies M. Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer. Cancer Treat Rev 2020; 85: 101979.
       </citation>
      </reference>
      <reference>
       <citation>
        Lung Cancer Study Group. Chinese thoracic society, Chinese Medical Association. [expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (trial version)]. Zhonghua Jie He He Hu Xi Za Zhi 2020; 43: E031. https://doi.org/10.3760/cma.j.cn112147-20200221-00138.
       </citation>
      </reference>
      <reference>
       <citation>
        Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-70.
       </citation>
      </reference>
      <reference>
       <citation>
        Alsaab HO, Sau S, Alzhrani R et al. PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: Mechanism, combinations, and clinical outcome. Front Pharmacol 2017; 8: 561.
       </citation>
      </reference>
      <reference>
       <citation>
        Santini FC, Hellmann MD. PD-1/PD-L1 Axis in lung cancer. Cancer J 2018; 24: 15-9.
       </citation>
      </reference>
      <reference>
       <citation>
        Villanueva N, Bazhenova L. New strategies in immunotherapy for lung cancer: Beyond PD-1/PD-L1. Ther Adv Respir Dis 2018; 12: 1753466618794133.
       </citation>
      </reference>
      <reference>
       <citation>
        Dadkhah B, Anisi E, Mozaffari N, Amani F, Pourghasemian M. Effect of music therapy with Periorbital massage on chemotherapy-induced nausea and vomiting in gastrointestinal cancer: A randomized Controlled Trail. J Caring Sci 2019; 8: 165-71.
       </citation>
      </reference>
      <reference>
       <citation>
        Karagozoglu S, Tekyasar F, Yilmaz FA. Effects of music therapy and guided visual imagery on chemotherapy-induced anxiety and nausea-vomiting. J Clin Nurs 2013; 22: 39-50.
       </citation>
      </reference>
      <reference>
       <citation>
        Raghavendra RM, Nagarathna R, Nagendra HR et al. Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. Eur J Cancer Care 2007; 16: 462-74.
       </citation>
      </reference>
      <reference>
       <citation>
        Carlisle PS, Gucalp R, Wiernik PH. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993; 14: 320-4.
       </citation>
      </reference>
      <reference>
       <citation>
        Binder D, Hubner RH, Temmesfeld-Wollbruck B, Schlattmann P. Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: A meta-analysis of clinical trials. Cancer Chemother Pharmacol 2011; 68: 1575-83.
       </citation>
      </reference>
      <reference>
       <citation>
        Li Y, Xia L. Coronavirus disease 2019 (COVID-19): Role of chest CT in diagnosis and management. Am J Roentgenol 2020; 4: 1-7.
       </citation>
      </reference>
      <reference>
       <citation>
        Dai WC, Zhang HW, Yu J et al. CT imaging and differential diagnosis of COVID-19. Can Assoc Radiol J 2020; 4: 846537120913033.
       </citation>
      </reference>
      <reference>
       <citation>
        Rubin EJ, Baden LR, Morrissey S. Audio interview: What clinicians need to know in diagnosing and treating Covid-19. N Engl J Med 2020; 382: e19.
       </citation>
      </reference>
      <reference>
       <citation>
        Wang C, Pan R, Wan X et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020; 17: E1729.
       </citation>
      </reference>
      <reference>
       <citation>
        Simard S, Thewes B, Humphris G et al. Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. J Cancer Surviv 2013; 7: 300-22.
       </citation>
      </reference>
      <reference>
       <citation>
        Duan L, Zhu G. Psychological interventions for people affected by the COVID-19 epidemic. Lancet Psychiatry 2020; 7: 300-2. https://doi.org/10.1016/S2215-0366(20)30073-0.
       </citation>
      </reference>
      <reference>
       <citation>
        Liu S, Yang L, Zhang C et al. Online mental health services in China during the COVID-19 outbreak. Lancet Psychiatry 2020; 7: e17-8. https://doi.org/10.1016/S2215-0366(20)30077-8.
       </citation>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32291278
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       15
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1095-9203
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          14
         </day>
        </pubdate>
       </journalissue>
       <title>
        Science (New York, N.Y.)
       </title>
       <isoabbreviation>
        Science
       </isoabbreviation>
      </journal>
      <articletitle>
       Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       eabb5793
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1126/science.abb5793
      </elocationid>
      <abstract>
       <abstracttext>
        It is urgent to understand the future of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) transmission. We used estimates of seasonality, immunity, and cross-immunity for betacoronaviruses OC43 and HKU1 from time series data from the USA to inform a model of SARS-CoV-2 transmission. We projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave. Absent other interventions, a key metric for the success of social distancing is whether critical care capacities are exceeded. To avoid this, prolonged or intermittent social distancing may be necessary into 2022. Additional interventions, including expanded critical care capacity and an effective therapeutic, would improve the success of intermittent distancing and hasten the acquisition of herd immunity. Longitudinal serological studies are urgently needed to determine the extent and duration of immunity to SARS-CoV-2. Even in the event of apparent elimination, SARS-CoV-2 surveillance should be maintained since a resurgence in contagion could be possible as late as 2024.
       </abstracttext>
       <copyrightinformation>
        Copyright Â© 2020, American Association for the Advancement of Science.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author equalcontrib="Y" validyn="Y">
        <lastname>
         Kissler
        </lastname>
        <forename>
         Stephen M
        </forename>
        <initials>
         SM
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0001-6000-8387
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author equalcontrib="Y" validyn="Y">
        <lastname>
         Tedijanto
        </lastname>
        <forename>
         Christine
        </forename>
        <initials>
         C
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0003-3403-5765
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Goldstein
        </lastname>
        <forename>
         Edward
        </forename>
        <initials>
         E
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0002-6795-0559
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author equalcontrib="Y" validyn="Y">
        <lastname>
         Grad
        </lastname>
        <forename>
         Yonatan H
        </forename>
        <initials>
         YH
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0001-5646-1314
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA. mlipsitc@hsph.harvard.edu ygrad@hsph.harvard.edu.
         </affiliation>
        </affiliationinfo>
       </author>
       <author equalcontrib="Y" validyn="Y">
        <lastname>
         Lipsitch
        </lastname>
        <forename>
         Marc
        </forename>
        <initials>
         M
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0003-1504-9213
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. mlipsitc@hsph.harvard.edu ygrad@hsph.harvard.edu.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        14
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Science
      </medlineta>
      <nlmuniqueid>
       0404511
      </nlmuniqueid>
      <issnlinking>
       0036-8075
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        04
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        09
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32291278
      </articleid>
      <articleid idtype="pii">
       science.abb5793
      </articleid>
      <articleid idtype="doi">
       10.1126/science.abb5793
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="In-Process">
     <pmid version="1">
      32290904
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Electronic">
        1560-7917
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         25
        </volume>
        <issue>
         14
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          04
         </month>
        </pubdate>
       </journalissue>
       <title>
        Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
       </title>
       <isoabbreviation>
        Euro Surveill.
       </isoabbreviation>
      </journal>
      <articletitle>
       Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.2807/1560-7917.ES.2020.25.14.2000433
      </elocationid>
      <abstract>
       <abstracttext>
        Healthcare workers (HCW) are potentially at increased risk of infection with coronavirus disease (COVID-19) and may transmit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to vulnerable patients. We present results from staff testing at Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom. Between 16 and 29 March 2020, 1,533 symptomatic HCW were tested, of whom 282 (18%) were positive for SARS-CoV-2. Testing HCW is a crucial strategy to optimise staffing levels during this outbreak.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Keeley
        </lastname>
        <forename>
         Alexander J
        </forename>
        <initials>
         AJ
        </initials>
        <affiliationinfo>
         <affiliation>
          The Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Evans
        </lastname>
        <forename>
         Cariad
        </forename>
        <initials>
         C
        </initials>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Colton
        </lastname>
        <forename>
         Hayley
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ankcorn
        </lastname>
        <forename>
         Michael
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cope
        </lastname>
        <forename>
         Alison
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         State
        </lastname>
        <forename>
         Amy
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bennett
        </lastname>
        <forename>
         Tracy
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Giri
        </lastname>
        <forename>
         Prosenjit
        </forename>
        <initials>
         P
        </initials>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         de Silva
        </lastname>
        <forename>
         Thushan I
        </forename>
        <initials>
         TI
        </initials>
        <affiliationinfo>
         <affiliation>
          The Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Raza
        </lastname>
        <forename>
         Mohammad
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          The Department of Infection, Immunity and Cardiovascular Disease, The Medical School, The University of Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
     </article>
     <medlinejournalinfo>
      <country>
       Sweden
      </country>
      <medlineta>
       Euro Surveill
      </medlineta>
      <nlmuniqueid>
       100887452
      </nlmuniqueid>
      <issnlinking>
       1025-496X
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="Y">
       COVID-19
      </keyword>
      <keyword majortopicyn="Y">
       SARS-CoV-2
      </keyword>
      <keyword majortopicyn="Y">
       diagnostic test
      </keyword>
      <keyword majortopicyn="Y">
       healthcare workers
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32290904
      </articleid>
      <articleid idtype="doi">
       10.2807/1560-7917.ES.2020.25.14.2000433
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      32290839
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       17
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       18
      </day>
     </daterevised>
     <article pubmodel="Electronic">
      <journal>
       <issn issntype="Electronic">
        1479-5876
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         18
        </volume>
        <issue>
         1
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          04
         </month>
         <day>
          14
         </day>
        </pubdate>
       </journalissue>
       <title>
        Journal of translational medicine
       </title>
       <isoabbreviation>
        J Transl Med
       </isoabbreviation>
      </journal>
      <articletitle>
       Why tocilizumab could be an effective treatment for severe COVID-19?
      </articletitle>
      <pagination>
       <medlinepgn>
        164
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1186/s12967-020-02339-3
      </elocationid>
      <abstract>
       <abstracttext>
        A severe pneumonia-associated respiratory syndrome caused by a new coronavirus was identified in December 2019 (COVID-19), spread rapidly and has become a world-wide public health challenge. About 25% of COVID-19 patients experienced severe complications including acute respiratory distress syndrome (ARDS), and even progressed into an intensive care unit (ICU) admission and died. The exploration for the mortality causes and advancing novel therapeutic development of severe COVID-19 is crucial at the moment. The biopsy samples analysis at autopsy suggested that increased alveolar exudate caused by aberrant host immune response and inflammatory cytokine storm probably impedes alveolar gas exchange and contributes to the high mortality of severe COVID-19 patients. Our research has identified that pathogenic T cells and inflammatory monocytes incite inflammatory storm with large amount of interleukin 6, therefore monoclonal antibody that targets the IL-6 pathways may potentially curb inflammatory storm. Moreover, Tocilizumab treatment that blocking IL-6 receptors showed inspiringÂ clinical results including temperature returned to normal quickly and respiratory function improved. Therefore, we suggest that Tocilizumab is an effective treatment in severe patients of COVID-19 to calmÂ the inflammatory storm and reduceÂ mortality.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Fu
        </lastname>
        <forename>
         Binqing
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Science and Medical Center, University of Science and Technology of China, Hefei, Anhui, 230001, China.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui, 230001, China.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Xu
        </lastname>
        <forename>
         Xiaoling
        </forename>
        <initials>
         X
        </initials>
        <affiliationinfo>
         <affiliation>
          The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wei
        </lastname>
        <forename>
         Haiming
        </forename>
        <initials>
         H
        </initials>
        <identifier source="ORCID">
         0000-0002-1675-6502
        </identifier>
        <affiliationinfo>
         <affiliation>
          Institute of Immunology and the CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Science and Medical Center, University of Science and Technology of China, Hefei, Anhui, 230001, China. ustcwhm@ustc.edu.cn.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei, Anhui, 230001, China. ustcwhm@ustc.edu.cn.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, China. ustcwhm@ustc.edu.cn.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         2020YFC0843800
        </grantid>
        <agency>
         the China National Center for Biotechnology Development 182
        </agency>
        <country>
         International
        </country>
       </grant>
       <grant>
        <grantid>
         81788101
        </grantid>
        <agency>
         the Natural Science Foundation of China
        </agency>
        <country>
         International
        </country>
       </grant>
       <grant>
        <grantid>
         81922028
        </grantid>
        <agency>
         the Natural Science Foundation of China
        </agency>
        <country>
         International
        </country>
       </grant>
       <grant>
        <grantid>
         2019442
        </grantid>
        <agency>
         Youth Innovation Promotion Association of Chinese Academy of Sciences
        </agency>
        <country>
         International
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016422">
        Letter
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        14
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       J Transl Med
      </medlineta>
      <nlmuniqueid>
       101190741
      </nlmuniqueid>
      <issnlinking>
       1479-5876
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D061067">
        Antibodies, Monoclonal, Humanized
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="C508600">
        IL6 protein, human
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D015850">
        Interleukin-6
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        I031V2H011
       </registrynumber>
       <nameofsubstance ui="C502936">
        tocilizumab
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <supplmeshlist>
      <supplmeshname type="Disease" ui="C000657245">
       COVID-19
      </supplmeshname>
      <supplmeshname type="Protocol" ui="C000705127">
       COVID-19 drug treatment
      </supplmeshname>
      <supplmeshname type="Organism" ui="C000656484">
       severe acute respiratory syndrome coronavirus 2
      </supplmeshname>
     </supplmeshlist>
     <citationsubset>
      IM
     </citationsubset>
     <commentscorrectionslist>
      <commentscorrections reftype="CommentIn">
       <refsource>
        J Transl Med. 2020 Apr 14;18(1):165
       </refsource>
       <pmid version="1">
        32290847
       </pmid>
      </commentscorrections>
     </commentscorrectionslist>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D061067">
        Antibodies, Monoclonal, Humanized
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D000073640">
        Betacoronavirus
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000276">
        immunology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015850">
        Interleukin-6
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000037">
        antagonists &amp; inhibitors
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D058873">
        Pandemics
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011024">
        Pneumonia, Viral
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000276">
        immunology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012720">
        Severity of Illness Index
       </descriptorname>
      </meshheading>
     </meshheadinglist>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="Y">
       Acute respiratory distress syndrome (ARDS)
      </keyword>
      <keyword majortopicyn="Y">
       COVID-19
      </keyword>
      <keyword majortopicyn="Y">
       IL-6
      </keyword>
      <keyword majortopicyn="Y">
       Inflammatory storm
      </keyword>
      <keyword majortopicyn="Y">
       SARS-CoV-2
      </keyword>
      <keyword majortopicyn="Y">
       Tocilizumab
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        16
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        09
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        18
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      epublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32290839
      </articleid>
      <articleid idtype="doi">
       10.1186/s12967-020-02339-3
      </articleid>
      <articleid idtype="pii">
       10.1186/s12967-020-02339-3
      </articleid>
      <articleid idtype="pmc">
       PMC7154566
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        J Thorac Oncol. 2020 Feb 28;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32114094
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Immunity. 2015 Sep 15;43(3):502-14
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26341401
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Semin Immunopathol. 2017 Jul;39(5):529-539
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28466096
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Feb 7;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32031570
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):497-506
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986264
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Respir Med. 2020 Apr;8(4):420-422
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32085846
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):470-473
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986257
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32290754
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       17
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1750-7448
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          14
         </day>
        </pubdate>
       </journalissue>
       <title>
        Immunotherapy
       </title>
       <isoabbreviation>
        Immunotherapy
       </isoabbreviation>
      </journal>
      <articletitle>
       Do checkpoint inhibitors compromise the cancer patients' immunity and increase the vulnerability to COVID-19 infection?
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.2217/imt-2020-0077
      </elocationid>
      <abstract>
       <abstracttext>
        The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) has been declared a pandemic by the WHO that claimed the lives of thousands of people within a few months. Cancer patients represent a vulnerable population due to the acquired immunodeficiency associated with anti-cancer therapy. Immune checkpoint inhibitors have largely impacted the prognosis of a multitude of malignancies with significant improvement in survival outcomes and a different, tolerable toxicity profile. In this paper, we assess the safety of ICI administration in cancer patients during the coronavirus pandemic in order to guide the usage of these highly efficacious agents.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Kattan
        </lastname>
        <forename>
         Joseph
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kattan
        </lastname>
        <forename>
         Clarisse
        </forename>
        <initials>
         C
        </initials>
        <affiliationinfo>
         <affiliation>
          Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Assi
        </lastname>
        <forename>
         Tarek
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016421">
        Editorial
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        14
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       Immunotherapy
      </medlineta>
      <nlmuniqueid>
       101485158
      </nlmuniqueid>
      <issnlinking>
       1750-743X
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       cancer
      </keyword>
      <keyword majortopicyn="N">
       checkpoints inhibitors
      </keyword>
      <keyword majortopicyn="N">
       coronavirus
      </keyword>
      <keyword majortopicyn="N">
       immune therapy
      </keyword>
      <keyword majortopicyn="N">
       immunosuppression
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32290754
      </articleid>
      <articleid idtype="doi">
       10.2217/imt-2020-0077
      </articleid>
      <articleid idtype="pmc">
       PMC7161588
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Science. 2011 Mar 25;331(6024):1565-70
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21436444
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2016 Dec 1;63(11):1490-1493
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27501841
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cancer. 2004 Jan 15;100(2):228-37
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14716755
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Eur J Cancer. 2016 Feb;54:139-148
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26765102
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Immunotherapy. 2019 May;11(7):591-598
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30943861
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Infection. 2014 Feb;42(1):5-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23975584
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Rev Clin Oncol. 2019 Sep;16(9):563-580
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31092901
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Feb 28;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32108857
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2017 Mar 16;376(11):1015-1026
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28212060
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Anticancer Drugs. 2017 Aug;28(7):811-814
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28574922
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2015 Jun 25;372(26):2521-32
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25891173
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        CA Cancer J Clin. 2018 Nov;68(6):394-424
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30207593
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Crit Rev Oncol Hematol. 2016 May;101:213-20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27051042
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Oncol. 2018 Mar;19(3):405-415
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29439857
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2015 Nov 5;373(19):1803-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26406148
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2018 Nov 29;379(22):2108-2121
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30345906
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Oncol Pract. 2019 Jan;15(1):19-24
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30629902
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Apr 11;395(10231):1225-1228
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32178769
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Oncol. 2016 Sep;17(9):1283-94
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27451390
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Mar 23;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32203977
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cell. 2011 Mar 4;144(5):646-74
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21376230
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Autoimmun. 2017 Dec;85:117-125
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28728794
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Microbiol Infect. 2018 Mar;24(3):216-218
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29269089
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Semin Cancer Biol. 2006 Feb;16(1):80-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16420981
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lung Cancer. 2016 Sep;99:123-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27565926
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Eur J Cancer. 2018 Nov;103:7-16
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30196108
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Immunother. 2020 Feb/Mar;43(2):67-74
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31498181
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2015 Oct 22;373(17):1627-39
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26412456
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2020 Feb 24;:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32091533
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Immunol Res. 2014;2014:286170
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24868562
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Oncol. 2020 Mar;21(3):335-337
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32066541
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="PubMed-not-MEDLINE">
     <pmid version="1">
      32288873
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       18
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Print">
        1871-1413
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         204
        </volume>
        <pubdate>
         <year>
          2017
         </year>
         <month>
          Oct
         </month>
        </pubdate>
       </journalissue>
       <title>
        Livestock science
       </title>
       <isoabbreviation>
        Livest Sci
       </isoabbreviation>
      </journal>
      <articletitle>
       Immune response of mature cows subjected to annual booster vaccination against neonatal calf diarrhoea with two different commercial vaccines: A non-inferiority study.
      </articletitle>
      <pagination>
       <medlinepgn>
        52-58
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.livsci.2017.08.011
      </elocationid>
      <abstract>
       <abstracttext>
        Neonatal calf diarrhoea can have important economic consequences. Scour vaccines are available against some of the most frequent pathogens responsible for this disease: Bovine Rotavirus (BoRV), Bovine Coronavirus (BoCV) and
        <i>
         E. coli
        </i>
        K99. In this multi-centre, randomised, blinded study, adult cows vaccinated with a trivalent vaccine marketed for years (Rotavecâ¢ Corona, MSD Animal Health - RC) prior to last parturition were revaccinated 12-15 months later, prior to the upcoming parturition, with either a single injection of a recently marketed vaccine (Bovigenâ¢ Scour, Virbac - BS), or RC. The aim of this trial was to verify whether BS is not inferior to RC for the stimulation of the immune response and the passive transfer to calves in these conditions. A total of 136 multiparous dairy cows, from 5 different herds and located in 3 countries (France, UK and Germany) were enrolled in the study. Sixty-five cows were vaccinated with BS and 71 with RC. Antibody levels, measured by competitive ELISA and represented as percentage of inhibition (PI), were assessed in the cow's serum (on the day of vaccination: D0 and on days 21, 42 and at calving), in the colostrum and in the serum of calves in the first week of life. Differences in means of PI between groups and the 95% confidence interval (CI) were calculated. The non-inferiority threshold was set at -10%. The relationships between antibody levels in the colostrum and the vaccination-calving interval (VCI) or the inter-booster vaccination interval (IBVI) were also analysed. All the lower margins of the 95% CI of the difference in means of PI, in all samples and for the 3 pathogens assessed, were above -10%. This result shows that BS is not inferior to RC for the stimulation of the immune response against BoRV, BoCV and
        <i>
         E. coli
        </i>
        K99 and the passive transfer of immunity to calves when this vaccine is administered to their dams previously vaccinated with RC. Furthermore, no correlation was found between PI values in the colostrum and the VCI or IBVI. The ratio of animals with a PI â¥ 95% in the colostrum, among cows with similar intervals, was not significantly different between groups, for all antigens tested. Therefore, this study shows that a single injection of the heterologous vaccine BS can be used as a booster in cattle previously vaccinated with RC.
       </abstracttext>
       <copyrightinformation>
        Â© 2017 VIRBAC S.A. Published by Elsevier B.V.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Durel
        </lastname>
        <forename>
         Luc
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          Virbac S.A., 13Ã¨me rue L.I.D., F-06511 Carros Cedex, France.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Rose
        </lastname>
        <forename>
         Clancy
        </forename>
        <initials>
         C
        </initials>
        <affiliationinfo>
         <affiliation>
          Virbac S.A., 13Ã¨me rue L.I.D., F-06511 Carros Cedex, France.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Virbac Ltd, Windmill Av., Woolpit Business Pk, Bury St. Edmunds, Sufolk IP30 9UP, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bainbridge
        </lastname>
        <forename>
         Tracy
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          The Park Vet Group, 82-84 High St, Whetstone, Leicestershire LE8 6LQ, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Roubert
        </lastname>
        <forename>
         Julien
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Clinique VÃ©tÃ©rinaire, 13 rue GÃ©nÃ©ral John S. Wood, F-35470 Bain de Bretagne, France.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Dressel
        </lastname>
        <forename>
         Klaus-Ulrich
        </forename>
        <initials>
         KU
        </initials>
        <affiliationinfo>
         <affiliation>
          Tierarzpraxis, Vahrholzer Str. 33, D-39624 Kalbe, Germany.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bennemann
        </lastname>
        <forename>
         Johanna
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          VIRBAC Tierarzneimittle GmbH, RÃ¶gen 20, D-23843 Bad Oldesloe, Germany.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         RÃ¼ckner
        </lastname>
        <forename>
         Antje
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Virology, Center for Infectious Diseases, Faculty of Veterinary Medicine, University of Leipzig, D-04109 Leipzig, Germany.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Vahlenkamp
        </lastname>
        <forename>
         Thomas
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Institute of Virology, Center for Infectious Diseases, Faculty of Veterinary Medicine, University of Leipzig, D-04109 Leipzig, Germany.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Maillard
        </lastname>
        <forename>
         Renaud
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Pathologie MÃ©dicale du BÃ©tail et des Animaux de Basse-Cour, Ecole Nationale VÃ©tÃ©rinaire de Toulouse, 23 Chemin des Capelles, F-31300 Toulouse, France.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2017
       </year>
       <month>
        08
       </month>
       <day>
        14
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Netherlands
      </country>
      <medlineta>
       Livest Sci
      </medlineta>
      <nlmuniqueid>
       101525137
      </nlmuniqueid>
      <issnlinking>
       1871-1413
      </issnlinking>
     </medlinejournalinfo>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Colostrum
      </keyword>
      <keyword majortopicyn="N">
       Coronavirus
      </keyword>
      <keyword majortopicyn="N">
       K99
      </keyword>
      <keyword majortopicyn="N">
       Neonatal calf diarrhoea
      </keyword>
      <keyword majortopicyn="N">
       Rotavirus
      </keyword>
      <keyword majortopicyn="N">
       Vaccine
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2017
       </year>
       <month>
        04
       </month>
       <day>
        09
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="revised">
       <year>
        2017
       </year>
       <month>
        08
       </month>
       <day>
        11
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2017
       </year>
       <month>
        08
       </month>
       <day>
        11
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        15
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2017
       </year>
       <month>
        10
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2017
       </year>
       <month>
        10
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32288873
      </articleid>
      <articleid idtype="doi">
       10.1016/j.livsci.2017.08.011
      </articleid>
      <articleid idtype="pii">
       S1871-1413(17)30234-2
      </articleid>
      <articleid idtype="pmc">
       PMC7102762
      </articleid>
     </articleidlist>
     <?pmcsd ?>
     <referencelist>
      <reference>
       <citation>
        J Vet Med Sci. 1997 Nov;59(11):1023-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         9409518
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Vet Clin North Am Food Anim Pract. 2010 Mar;26(1):123-46, table of contents
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20117547
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Vet Res. 1999 Mar-Jun;30(2-3):259-84
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         10367358
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Vet Parasitol. 2010 Sep 20;172(3-4):221-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20541870
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Prev Vet Med. 2015 Jan 1;118(1):64-70
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25475689
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virol J. 2011 Jan 05;8:3
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21205330
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Vet Sci. 2014;15(1):1-17
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24378583
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ir Vet J. 2011 Sep 14;64(1):9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21917151
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Br Vet J. 1993 Jan-Feb;149(1):51-70
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         8382546
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 1984 Sep;20(3):342-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6092421
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 1995 Dec;33(12):3264-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         8586714
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Vet Intern Med. 2000 Nov-Dec;14(6):569-77
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         11110376
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ir Vet J. 2014 Jun 20;67(1):13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24987518
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 1991 Nov;29(11):2668-72
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         1723075
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Iran J Vet Res. 2016 Winter;17(1):8-12
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27656222
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Vet Res. 1999 Sep-Oct;30(5):509-22
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         10543385
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Front Cell Infect Microbiol. 2015 Mar 12;5:23
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25815276
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Vet Rec Open. 2014 Jul 11;1(1):e000042
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26392877
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 1991 Mar;29(3):483-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         1709946
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Arch Virol. 2011 Aug;156(8):1397-413
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21597953
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Curr Opin Immunol. 2009 Jun;21(3):346-51
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19500964
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS One. 2016 Mar 17;11(3):e0150452
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26986832
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Acta Vet Scand. 2010 Jun 04;52:37
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20525326
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 1990 Mar;28(3):504-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         2157736
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Prev Vet Med. 2010 Feb 1;93(2-3):162-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19819574
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Can Vet J. 1977 May;18(5):113-21
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         326373
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Can Vet J. 1991 Mar;32(3):155-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17423753
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Acta Vet Scand. 2014 Nov 25;56:75
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25431305
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Exp Vaccine Res. 2013 Jul;2(2):97-105
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23858400
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Can Vet J. 2003 Nov;44(11):907-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14664353
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Dairy Sci. 2008 Oct;91(10):3840-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18832206
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Anim Health Res Rev. 2001 Dec;2(2):129-40
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         11831435
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Gen Virol. 1991 Jul;72 ( Pt 7):1559-67
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         1649894
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Can Vet J. 1994 Mar;35(3):163-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         8055431
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Dairy Sci. 2014 Nov;97(11):6991-7000
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25200772
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 2002 Nov;40(11):4367-71
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12409434
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Rev Argent Microbiol. 2015 Apr-Jun;47(2):95-102
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26026231
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 1986 Aug 23;2(8504):417-21
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         2874413
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="PubMed-not-MEDLINE">
     <pmid version="1">
      32288321
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       18
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Print">
        0953-7112
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         15
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          2004
         </year>
         <month>
          Aug
         </month>
        </pubdate>
       </journalissue>
       <title>
        Current anaesthesia and critical care
       </title>
       <isoabbreviation>
        Curr Anaesth Crit Care
       </isoabbreviation>
      </journal>
      <articletitle>
       Severe acute respiratory syndrome (SARS) in intensive care units (ICUs): limiting the risk to healthcare workers.
      </articletitle>
      <pagination>
       <medlinepgn>
        143-155
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.cacc.2004.05.003
      </elocationid>
      <abstract>
       <abstracttext>
        The global epidemic of severe acute respiratory syndrome (SARS) during the first half of 2003 resulted in over 8000 cases with more than 800 deaths. Many of those who eventually died, did so in the critical (intensive) care units of various hospitals around the world, and many secondary cases of SARS arose in healthcare workers looking after such patients in these units. Research on SARS coronavirus (SARS CoV) demonstrated that this virus belongs to the same family of viruses, the
        <i>
         Coronaviridae
        </i>
        that causes the common cold, with some important differences. Properties of this virus have been discovered which can be used to develop important infection control policies within hospitals to limit the number of secondary cases. These properties include environmental survival, transmissibility, viral load in various organs and fluids and periods of symptomatic illness during which infectivity is greatest. Various barrier methods were used throughout the epidemic to protect healthcare workers from SARS, with varying degrees of success. Treatment of SARS patients has mainly involved steroid therapy, with or without ribavirin, but there is no consensus on the best treatment protocol, as yet. This review focuses on the implications of SARS for healthcare workers and patients on critical care units.
       </abstracttext>
       <copyrightinformation>
        Copyright Â© 2004 Elsevier Ltd. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Tang
        </lastname>
        <forename>
         J W
        </forename>
        <initials>
         JW
        </initials>
        <affiliationinfo>
         <affiliation>
          Royal Free and University College Medical Schools, Centre for Virology, Division of Infection and Immunity, Windeyer Building, 46 Cleveland Street, London W1T 4JF, UK.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chan
        </lastname>
        <forename>
         R C W
        </forename>
        <initials>
         RCW
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Microbiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administration Region (SAR), China.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2004
       </year>
       <month>
        06
       </month>
       <day>
        26
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Netherlands
      </country>
      <medlineta>
       Curr Anaesth Crit Care
      </medlineta>
      <nlmuniqueid>
       9007263
      </nlmuniqueid>
      <issnlinking>
       0953-7112
      </issnlinking>
     </medlinejournalinfo>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Healthcare workers
      </keyword>
      <keyword majortopicyn="N">
       Infection control
      </keyword>
      <keyword majortopicyn="N">
       Intensive care
      </keyword>
      <keyword majortopicyn="N">
       SARS
      </keyword>
      <keyword majortopicyn="N">
       Severe acute respiratory syndrome
      </keyword>
      <keyword majortopicyn="N">
       Transmission
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        15
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2004
       </year>
       <month>
        8
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2004
       </year>
       <month>
        8
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32288321
      </articleid>
      <articleid idtype="doi">
       10.1016/j.cacc.2004.05.003
      </articleid>
      <articleid idtype="pii">
       S0953-7112(04)00082-1
      </articleid>
      <articleid idtype="pmc">
       PMC7135788
      </articleid>
     </articleidlist>
     <?pmcsd ?>
     <referencelist>
      <reference>
       <citation>
        Intensive Care Med. 2003 Jun;29(6):870-875
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12739014
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2003 Jul 16;290(3):367-73
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12865378
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):1977-85
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12671062
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        BMJ. 2004 Jan 24;328(7433):195
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14726369
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):334-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030707
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Nov;9(11):1491-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14725258
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):342-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030709
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Crit Care Med. 2003 Nov;31(11):2684-92
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14605542
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        BMJ. 2003 Jun 21;326(7403):1358-62
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12816821
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):287-93
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030699
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        BMJ. 2004 Jan 10;328(7431):65
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14715581
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 2003 Oct;41(10):4521-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14532176
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):1953-66
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12690092
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):2029
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12748319
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2003 Jun 4;289(21):2801-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12734147
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Science. 2003 Jun 20;300(5627):1966-70
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12766207
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):304-10
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030702
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Emerg Med. 2004 Jan;43(1):6-14
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14707933
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        CMAJ. 2004 Jan 20;170(2):183
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14734423
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Radiology. 2004 Feb;230(2):339-46
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14752179
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        AJR Am J Roentgenol. 2003 Jul;181(1):25-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12818824
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        CMAJ. 2003 Jun 24;168(13):1649-60
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12821618
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Radiology. 2003 Nov;229(2):492-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14526098
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 May 17;361(9370):1730-3
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12767752
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        World J Gastroenterol. 2003 Jun;9(6):1139-43
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12800213
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Oct;9(10):1205-10
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14609453
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Science. 2003 Jun 20;300(5627):1961-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12766206
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):311-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030703
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        QJM. 2003 Nov;96(11):845-52
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14566040
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):345-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030710
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Science. 2003 Oct 10;302(5643):276-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12958366
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):251-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030692
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        AJR Am J Roentgenol. 2004 Feb;182(2):493-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14736688
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2004 Feb 15;38(4):585-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14765354
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Sep;9(9):1042-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14519237
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Virol. 2004 Jan;29(1):13-22
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14675864
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):1986-94
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12682352
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Sep;9(9):1064-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14519241
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 May 24;361(9371):1767-72
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12781535
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 Nov 29;362(9398):1807-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14654320
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Med Sci Monit. 2003 Jun;9(6):SR29-34
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12824965
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 Dec 13;362(9400):2025-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14683674
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Chin Med J (Engl). 2004 Jan;117(1):14-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14733766
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2004 Feb 15;189(4):642-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14767817
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Sep;9(9):1182-3
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14531381
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Nov;9(11):1381-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14718079
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        CMAJ. 2003 May 27;168(11):1415-20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12771070
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 Jul 26;362(9380):293-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12892961
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Respir Crit Care Med. 2004 Jan 1;169(1):125-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14695107
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):256-60
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030693
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):1967-76
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12690091
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):300-3
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030701
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Br J Anaesth. 2004 Feb;92(2):280-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14722185
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):317-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030704
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Sep;9(9):1180-1
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14531379
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Science. 2003 Jun 20;300(5627):1884-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12766208
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Intensive Care Med. 2004 Mar;30(3):381-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14740156
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):1995-2005
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12671061
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):261-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030694
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2004 Apr 22;350(17):1731-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15102999
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Pediatr Pulmonol. 2003 Oct;36(4):261-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12950037
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        AJR Am J Roentgenol. 2003 Jul;181(1):3-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12818821
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Pediatrics. 2004 Feb;113(2):e146-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14754985
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):339-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030708
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):2030-1
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12672880
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2004 Jan 15;38(2):293-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14699465
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Emerg Med. 2004 Jan;43(1):27-33
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14707937
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Emerg Med. 2004 Jan;43(1):34-42
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14707938
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 May 17;361(9370):1701-3
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12767737
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 Dec 18;349(25):2468-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14681520
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Emerg Med. 2004 Jan;43(1):1-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14707932
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Microbiol. 2003 Aug;52(Pt 8):715-720
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12867568
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        BMJ. 2003 Jun 21;326(7403):1393
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12816834
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Med J Aust. 2003 Jun 2;178(11):555-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12765503
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Science. 2003 Jun 13;300(5626):1763-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12746549
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        AACN Clin Issues. 2004 Jan-Mar;15(1):150-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14767372
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):294-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030700
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Apr;10(4):587-92
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15200846
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Science. 2004 Jan 16;303(5656):292
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14726558
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Singapore Med J. 2003 Apr;44(4):201-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12952033
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Occup Environ Med. 2003 Jul;60(7):528
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12819288
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        JAMA. 2003 Jul 16;290(3):374-80
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12865379
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):280-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030698
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Mar;10(3):544-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15116707
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Comput Assist Tomogr. 2004 Jan-Feb;28(1):1-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14716225
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Intern Med. 2003 Nov 4;139(9):715-23
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14597455
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2003 Nov;3(11):679
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14603886
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 2004 Jan;42(1):347-50
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14715775
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2004 Jan 10;363(9403):134
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14733188
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Acad Emerg Med. 2004 Feb;11(2):156-61
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14759957
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        AJR Am J Roentgenol. 2003 Jul;181(1):19-24
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12818823
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        AJR Am J Roentgenol. 2003 Jul;181(1):11-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12818822
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Nov;9(11):1453-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14718090
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 May 3;361(9368):1486-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12737853
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 Jun 14;361(9374):2045-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12814717
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 May 3;361(9368):1558
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12737884
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Science. 2003 May 30;300(5624):1394-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12730500
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Emerg Med. 2004 Jan;43(1):17-22
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14707935
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Microbiol. 2003 Dec;41(12):5781-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14662982
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 Dec 6;362(9399):1895-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14667748
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Mar;10(3):389-94
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15109402
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):277-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030697
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2002 May 1;34 Suppl 2:S48-51
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         11938496
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):269-76
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030696
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2002 May 1;34 Suppl 2:S58-64
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         11938498
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 May 24;361(9371):1761-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12781533
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        CMAJ. 2003 Aug 19;169(4):285-92
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12925421
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 May 3;361(9368):1519-20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12737864
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 Dec 18;349(25):2431-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14681510
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Pineal Res. 2003 Aug;35(1):69-70
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12823616
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Mar;10(3):395-400
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15109403
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Curr Med Res Opin. 2004 Jan;20(1):39-40
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14741070
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Acta Biochim Biophys Sin (Shanghai). 2004 Jan;36(1):37-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14732873
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2003 Jun;9(6):713-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12781012
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2004 Feb 15;38(4):483-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14765339
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2004 Jan 17;363(9404):234-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14738798
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14983044
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Tradit Chin Med. 2003 Sep;23(3):214-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14535196
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Epidemiol Community Health. 2003 Oct;57(10):766-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14573569
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Science. 2003 May 30;300(5624):1399-404
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12730501
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 Aug 16;362(9383):570-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12932393
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Virol. 2003 Dec;28(3):233-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14522060
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        ACP J Club. 2004 Jan-Feb;140(1):19
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14711290
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Feb;10(2):327-33
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030706
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2004 Apr 22;350(17):1710-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15102996
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2004 Mar;10(3):530-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15109430
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="PubMed-not-MEDLINE">
     <pmid version="1">
      32288184
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       18
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Print">
        0769-2617
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         138
        </volume>
        <issue>
         2
        </issue>
        <pubdate>
         <medlinedate>
          1987 Apr-Jun
         </medlinedate>
        </pubdate>
       </journalissue>
       <title>
        Annales de l'Institut Pasteur. Virology
       </title>
       <isoabbreviation>
        Ann. Inst. Pasteur Virol.
       </isoabbreviation>
      </journal>
      <articletitle>
       EnquÃªte sÃ©rologique par immunofluorescence indirecte, sur les infections Ã  coronavirus OC
       <sub>
        43
       </sub>
       .
      </articletitle>
      <pagination>
       <medlinepgn>
        263-268
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/S0769-2617(87)80010-2
      </elocationid>
      <abstract>
       <abstracttext>
        Four-hundred seventy-two sera were examined by the indirect immunofluorescence test against Coronavirus strain OC
        <sub>
         43
        </sub>
        adapted to the HRT
        <sub>
         18
        </sub>
        cell culture. Sera were from children and adults hospitalized over a 4-year period, from 1979 to 1982, at the CHRU of Clermont-Ferrand (France) for different clinical reasons. Of the 446 sera tested, 61 % showed antibodies against OC
        <sub>
         43
        </sub>
        ; 90 % of adult sera were positive. Coronavirus infections are very common in France. Immunity appears early in life, and infection is frequent in children from 12-36 months of age.
       </abstracttext>
       <copyrightinformation>
        Copyright Â© 1987 Published by Elsevier Masson SAS.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Chambon
        </lastname>
        <forename>
         M
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Service de Microbiologie, UER Pharmacie (Pr Joly), Clermont-Ferrand.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Laveran
        </lastname>
        <forename>
         H
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Service d'HygiÃ¨ne HospitaliÃ¨re (Pr Beytout), Clermont-Ferrand.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         L'Haridon
        </lastname>
        <forename>
         R
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Service de Recherches de Virologie et d'Immunologie, INRA, Thiverval-Grignon.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Peigue-Lafeuille
        </lastname>
        <forename>
         H
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Service de BactÃ©riologie Virologie (Pr Cluzel), FacultÃ© de MÃ©decine, Clermont-Ferrand (France).
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Trimolet
        </lastname>
        <forename>
         M
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Service de BactÃ©riologie Virologie (Pr Cluzel), FacultÃ© de MÃ©decine, Clermont-Ferrand (France).
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Beytout
        </lastname>
        <forename>
         D
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Service d'HygiÃ¨ne HospitaliÃ¨re (Pr Beytout), Clermont-Ferrand.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2009
       </year>
       <month>
        09
       </month>
       <day>
        23
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Netherlands
      </country>
      <medlineta>
       Ann Inst Pasteur Virol
      </medlineta>
      <nlmuniqueid>
       8702442
      </nlmuniqueid>
      <issnlinking>
       0769-2617
      </issnlinking>
     </medlinejournalinfo>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Coronavirus, Immunofluorescence
      </keyword>
      <keyword majortopicyn="N">
       Diagnosis, Seroepidemiology
      </keyword>
      <keyword majortopicyn="N">
       Diagnostic, SÃ©ro-Ã©pidÃ©miologie
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        1986
       </year>
       <month>
        09
       </month>
       <day>
        15
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        1986
       </year>
       <month>
        12
       </month>
       <day>
        15
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        15
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        1987
       </year>
       <month>
        4
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        1987
       </year>
       <month>
        4
       </month>
       <day>
        1
       </day>
       <hour>
        0
       </hour>
       <minute>
        1
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32288184
      </articleid>
      <articleid idtype="doi">
       10.1016/S0769-2617(87)80010-2
      </articleid>
      <articleid idtype="pii">
       S0769-2617(87)80010-2
      </articleid>
      <articleid idtype="pmc">
       PMC7135872
      </articleid>
     </articleidlist>
     <?pmcsd ?>
     <referencelist>
      <reference>
       <citation>
        Am J Epidemiol. 1971 Jul;94(1):43-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         5556222
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am Rev Respir Dis. 1972 May;105(5):805-11
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         5020629
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 1982 Jan;145(1):27-36
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6274967
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 1974 Mar;129(3):271-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         4816305
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        C R Seances Acad Sci D. 1980 Mar 31;290(13):869-72
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6248262
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Infect Immun. 1981 Sep;33(3):734-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6169641
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Epidemiol. 1970 Jun;91(6):585-92
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         4315625
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        C R Seances Acad Sci D. 1980 Mar 3;290(9):623-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6768468
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Vet Res. 1973 Feb;34(2):145-50
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         4568246
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Microbiol (Paris). 1978 Jul;129B(1):101-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         214002
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Hyg (Lond). 1972 Jun;70(2):235-44
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         4503867
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Ann Rech Vet. 1981;12(3):243-51
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6284011
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Epidemiol. 1975 Mar;101(3):238-44
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         1115061
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 1977 Feb;135(2):201-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         65439
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Epidemiol. 1986 May;123(5):862-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         3008551
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Scand J Infect Dis. 1974;6(4):325-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         4450100
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Soc Exp Biol Med. 1977 Jun;155(2):143-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         194251
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
  </pubmedarticleset>
 </body>
</html>